{"schema_version":"secwatch.filing_event.v1","accession":"0001396814-25-000022","form_type":"8-K","ticker":"PCRX","cik":"0001396814","company_name":"Pacira BioSciences, Inc.","filed_at":"2025-01-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.516586+00:00","generated_at":"2026-05-27T05:13:11.438044+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Pacira BioSciences appoints Laura Brege as Board Chair; two directors retire","bullets":["Paul J. Hastings (former Chair) and Andreas Wicki retired effective Jan. 28, 2025; no disagreement cited.","Laura Brege appointed Chair; brings 30 years pharma/biotech executive experience.","Board reduced from 12 to 9 directors; 8 of 9 are independent; 5 joined since Oct. 2023.","Alethia Young succeeds Brege as Audit Committee Chair; other committee assignments refreshed.","Brege previously held leadership roles at BridgeBio, Onyx Pharmaceuticals, and COR Therapeutics."],"urls":{"canonical":"https://secwatch.observer/filing/0001396814-25-000022","json":"https://secwatch.observer/filing/0001396814-25-000022.json","markdown":"https://secwatch.observer/filing/0001396814-25-000022.md","text":"https://secwatch.observer/filing/0001396814-25-000022.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000022/0001396814-25-000022-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000022/pcrx-20250128.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T05:13:11.438044+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"408401d987","claim":"Paul J. Hastings resigned as Chair of the Board at Pacira BioSciences, Inc..","evidence_excerpt":"On January 28, 2025, Paul J. Hastings, Chair of the Board of Directors (the “Board”), and Andreas Wicki, a member of the Board, each notified the Board of Pacira BioSciences, Inc. (the “Company”) of his respective decision to resign as a member of the Board, in each case, effective immediately","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000022/0001396814-25-000022-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chair of the Board"}]},{"claim_id":"7084facc8d","claim":"Andreas Wicki resigned as Member of the Board at Pacira BioSciences, Inc..","evidence_excerpt":"On January 28, 2025, Paul J. Hastings, Chair of the Board of Directors (the “Board”), and Andreas Wicki, a member of the Board, each notified the Board of Pacira BioSciences, Inc. (the “Company”) of his respective decision to resign as a member of the Board, in each case, effective immediately","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000022/0001396814-25-000022-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Member of the Board"}]},{"claim_id":"cfcbfaa777","claim":"Laura Brege was appointed as Chair of the Board at Pacira BioSciences, Inc..","evidence_excerpt":"the Board, upon recommendation of the Nominating, Governance and Sustainability Committee of the Board, appointed Laura Brege as Chair of the Board, effective as of immediately following the effectiveness of the Resignations.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000022/0001396814-25-000022-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chair of the Board"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}